US 11,938,298 B2
Medical injection device packaging
Mark Horlock, Timperley (GB)
Assigned to Teva Pharmaecutical Industries Ltd., Petah Tiqva (IL)
Filed by Teva Pharmaecutical Industries Ltd., Petah Tiqva (IL)
Filed on May 7, 2023, as Appl. No. 18/144,233.
Application 18/144,233 is a continuation of application No. 15/840,150, filed on Dec. 13, 2017, granted, now 11,642,451, issued on May 9, 2023.
Claims priority of application No. 1621275 (GB), filed on Dec. 14, 2016.
Prior Publication US 2023/0302216 A1, Sep. 28, 2023
Int. Cl. A61M 5/00 (2006.01)
CPC A61M 5/002 (2013.01) [A61M 5/008 (2013.01); A61M 2209/06 (2013.01)] 29 Claims
OG exemplary drawing
 
1. A kit comprising a packaging and an injection device,
wherein the injection device defines a positioning recess,
wherein the packaging comprises:
a channel extending longitudinally to accommodate the injection device, the channel including a first longitudinal wall, a second longitudinal wall opposing the first longitudinal wall, and a base wall extending between the first longitudinal wall and the second longitudinal wall;
a first handling recess defined by the first longitudinal wall and a second handling recess defined by the second longitudinal wall; and
a positioning rib protruding from the base wall into the channel for insertion into the positioning recess of the injection device, the positioning rib having a length in the longitudinal direction that is greater than a width in the lateral direction,
wherein a lateral position of the positioning rib is central in the channel and a longitudinal position of the positioning rib is eccentric in the channel.